Started 2 Units for Injectables, Ointments and Nasal Drops. Established Presence in Germany.
Started a new division for Veterinary APIs and Formulations.
Started a new division for Nutraceutical Products.
Started production at EU-GMP approved unit for solid dosage forms. Commenced registration of Finished Formulations in CIS countries and Latin America. Company's turnover crossed USD 25 million. Established presence in United Kingdom.
Acquired new API Manufacturing Plant with purification technology.
Company turnover crossed USD 10 Million.
Started production of Anti-Malarial APIs at a new cGMP Unit.
Began South East Asian operations in Thailand, Philippines, Hong Kong, Malaysia and Myanmar.
Established presence in Latin America.
Obtained WHO-GMP for manufacturing facilities and began production of Finished Formulations.
Started production of APIs from advanced intermediates developed in-house.